|
Mark D. Erion Ph.D. Director Executive Vice President of Research and Development and Chief Scientific Officer - Mark D. Erion Ph.D. is one of our founders and has served as our Executive Vice President of Research and Development since April 1997 and on our board of directors since June 1999. Prior to joining Metabasis Dr. Erion was with Gensia where he served as Director of Chemistry and Biochemistry from 1991 and assumed responsibility for research in 1996. Prior to joining Gensia Dr. Erion was a Group Leader at Ciba-Geigy Pharmaceutical Company from where he directed a team in the area of protein engineering. Dr. Erion's research has resulted in over 80 publications and 25 U.S. patents. His discovery efforts over the past 12 years have produced seven clinical candidates several research collaborations and more recently our HepDirect and NuMimetic technologies. Dr. Erion received a B.S. in mathematics and chemistry from the University of Oregon a Ph.D. in Chemistry from Cornell University and was a National Institutes of Health postdoctoral fellow in enzymology at the Massachusetts Institute of Technology.
| 